Phytotherapy Research · 2009 · 27 citations · 13 references
MedicineBotanyPharmacologyBiochemical PharmacologyDrug DiscoveryPlant BiochemistryHyperpigmentation TreatmentPigment Biosynthesis InhibitionPigmentary DisordersMelanin AccumulationMelanin BiosynthesisMelanin FormationMelanin ProductionMelanin SynthesisMelanocyte-stimulating HormonePharmacological ScreeningSkin Hyperpigmentation
Hyperpigmentation disorders such as freckles and senile lentigines in the skin are associated with abnormal accumulation of melanin pigments. In this study, two lignan constituents were isolated from Saururus chinensis Baill (Saururaceae) as inhibitors of cellular melanin production by bioassay-guided fractionations. The active constituents were manassantin A and B that dose-dependently inhibited melanin production in alpha-melanocyte stimulating hormone (alpha-MSH)-activated melanoma B16 cells with IC(50) values of 13 nm and 8 nm, respectively. Arbutin as a positive control exhibited an IC(50) value of 96 microm on alpha-MSH-induced melanin production. Further, manassantin A inhibited forskolin- or 3-isobutyl-1-methylxanthine (IBMX)-induced melanin production with IC(50) values of 14 nm or 12 nm, respectively. Manassantin A decreased cellular amounts of IBMX-inducible tyrosinase protein but could not affect the catalytic activity of cell-free tyrosinase, a key enzyme in the biosynthetic pathway of melanin pigments. Finally, this study could provide a pharmacological potential of S. chinensis in hyperpigmentation disorders.
13
Oxyresveratrol and Hydroxystilbene Compounds
Yeon Mi Kim, Jieun Yun, Chong‐Kil Lee et al. · Journal of Biological Chemistry · 2002 · 322 citations · Full text
Corine Bertolotto, Roser Buscà, Patricia Abbe et al. · Molecular and Cellular Biology · 1998 · 310 citations · Full text
Christine Roméro-Graillet, Édith Aberdam, Naïma Biagoli et al. · Journal of Biological Chemistry · 1996 · 178 citations · Full text